Literature DB >> 24346537

Recombinant human annexin A5: a novel drug candidate for treatment of sepsis?

Guochang Hu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24346537      PMCID： PMC3995449          DOI： 10.1097/01.ccm.0000435680.21801.0f

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  15 in total

Review 1.  Accessory molecules for Toll-like receptors and their function.

Authors:  Clarissa C Lee; Ana M Avalos; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2012-02-03       Impact factor: 53.106

Review 2.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Immunity       Date:  2011-05-27       Impact factor: 31.745

3.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

Review 4.  Annexins: linking Ca2+ signalling to membrane dynamics.

Authors:  Volker Gerke; Carl E Creutz; Stephen E Moss
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

5.  Annexin A5 is not essential for skeletal development.

Authors:  Bent Brachvogel; Jörg Dikschas; Helga Moch; Heike Welzel; Klaus von der Mark; Clementine Hofmann; Ernst Pöschl
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 6.  TLR based therapeutics.

Authors:  Aisling Dunne; Neil A Marshall; Kingston H G Mills
Journal:  Curr Opin Pharmacol       Date:  2011-04-16       Impact factor: 5.547

7.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

8.  Recombinant human annexin A5 inhibits proinflammatory response and improves cardiac function and survival in mice with endotoxemia.

Authors:  Paul Arnold; Xiangru Lu; Fatemeh Amirahmadi; Katharina Brandl; J Malcolm O Arnold; Qingping Feng
Journal:  Crit Care Med       Date:  2014-01       Impact factor: 7.598

9.  Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity.

Authors:  Jacob H Rand; Xiao-Xuan Wu; Elaine Y Lin; Alexander Griffel; Philip Gialanella; John C McKitrick
Journal:  mBio       Date:  2012-03-13       Impact factor: 7.867

10.  Annexin-A5 assembled into two-dimensional arrays promotes cell membrane repair.

Authors:  Anthony Bouter; Céline Gounou; Rémi Bérat; Sisareuth Tan; Bernard Gallois; Thierry Granier; Béatrice Langlois d'Estaintot; Ernst Pöschl; Bent Brachvogel; Alain R Brisson
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.